News - Natural Venures Puerto Rico https://web.tmxmoney.com/article.php?newsid=5787965205524001&qm_symbol=CSI:CNX VANCOUVER, British Columbia, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), is proud to announce its subsidiary, Natural Ventures, has signed an exclusive offtake agreement with HempRico LLC, (“HempRico”). HempRico has received a hemp cultivation license in Puerto Rico, and will begin planting an initial high-potency hemp crop in the coming weeks. Natural Ventures is continuing to work with cultivators in Puerto Rico, by providing cultivators with direct access to high-quality manufacturing services. With the agreement with HempRico, the Company will manufacture high-potency CBD products for the medical market through finished goods such as tinctures, patches, edibles, and other high-CBD hemp-derived products. These products will be manufactured to a high standard to ensure compliance for distribution to international markets. HempRico’s cultivation area is located in Cayey, a mountainous municipality that has a unique micro-climate for growing. The Company expects the elevation will provide consistently high-CBD crops that will be used to supply the medical market. “Through this exclusive offtake agreement, Natural Ventures receives additional biomass and thus ensures our facilities receive a consistent supply of raw material from various sources,” said Chief Executive Officer, Edgar Montero. “Bolstering our production capability is a key element to ensure the Company is able to process the increasing amount of high-CBD crops. As Puerto Rico issues more licenses, Natural Ventures will work with cultivators and provide extraction and finished good manufacturing.”